Nootropics News Hubb
Advertisement Banner
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact
No Result
View All Result
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact
No Result
View All Result
Wellnessnewshubb
No Result
View All Result
Home Neuroscience

Optimizing Choice of Dual Antiplatelet Therapy in CYP2C19 Loss-of-Function Carriers

admin by admin
February 2, 2023
in Neuroscience


There is limited knowledge regarding the most efficacious antiplatelet treatment to reduce subsequent stroke risk for patients with CYP2C19 loss-of-function (LOF) alleles presenting with acute cerebrovascular events. Clopidogrel is an inactive prodrug and requires conversion to an active metabolite through the CYP2C19 enzyme.1 Individuals who carry 2 LOF alleles for the CYP2C19 gene are poor metabolizers of clopidogrel, and clopidogrel may be less effective in these patients.1 CYP2C19 LOF alleles are more common in East Asian populations. At least 1 CYP2C19 LOF allele is present in approximately 24% of non-Hispanic White individuals, 33% of Black individuals, 18% of Hispanic individuals, and 50% of Asian individuals.2 Carriers of these LOF alleles were found to have a higher risk of ischemic stroke compared with noncarriers when treated with clopidogrel.3



Source link

Previous Post

The clinical relevance of anti-glutamic acid decarboxylase antibodies in children with encephalitis/encephalopathy

Next Post

In a Long Term Relationship But Have Feelings For Someone Else

Next Post

In a Long Term Relationship But Have Feelings For Someone Else

Recommended

Quality control practices in FMRI analysis: Philosophy, methods and examples using AFNI

2 months ago

Questionnaires based on natural language processing elicit immersive ruminative thinking in ruminators: Evidence from behavioral responses and EEG data

2 weeks ago

Bicycle airbag backpack blows up womb-like head and neck protection

2 months ago

Marcia Hunter Wants You to Follow Your Dreams

3 weeks ago

A new look at the role of NMDA in brain function and psychiatric disorders

5 months ago

Restoring the missing person to personalized medicine and precision psychiatry

1 month ago

© 2022 Nootropics News Hubb All rights reserved.

Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.

Navigate Site

  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact

Newsletter Sign Up.

No Result
View All Result
  • Home
  • News
  • Neuroscience
  • Creative Thinking
  • Food & Supplements
  • Contact

© 2022 Nootropics News Hubb All rights reserved.